ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2018

Go back to ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2018

Needham & Company Upgrades ResMed (RMD) to Hold

January 23, 2018 7:34 AM EST

Needham & Company upgraded ResMed (NYSE: RMD) from Underperform to Hold.

Analyst Mike Matson commented, "RMD's revenue and EPS both significantly beat consensus in F2Q18. Organic revenue growth improved to 11% in F2Q18 from 10% in F1Q18 as RMD saw both stronger... More